Abstract
There is much interest in developmentally regulated molecules which may have function in cell interactions and sorting during embryogenesis and differentiation. Numerous antisera have been raised which detect antigens that are expressed in early embryonic cells and become restricted during differentiation, being expressed in only a minority of adult cells (reviewed in refs 1–3). The precise antigenic determinants recognized by such antisera have not been defined. However, studies using a hybri-doma antibody against mouse spleen cells4 and monoclonal autoantibodies of patients with cold agglutinin disease5 have shown that two defined carbohydrate antigen systems, the Forssman and the li antigens, have stage-specific expression in early mouse embryos. We now describe evidence that the stage-specific embryonic antigen SSEA-1 (ref. 6) involves the carbohydrate sequence Galβ1 → 4GlcNAc ↑1,3 Fucα This determinant is formed by α 1 → 3 fucosylation of blood group I or i antigens which are branched or linear oligosaccharides, respectively7–9, built of Galβ1 →4GlcNAc units and known as type 2 precursor chains10 of the major blood group antigens. Thus, we introduce the concept of simple glycosylation changes as a basis for stage-specific expression of embryonic antigens.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Jacob, F. Curr. Topics dev. Biol. 13, 117–137 (1979).
Solter, D. & Knowles, B. B. Curr. Topics dev. Biol 13, 139–165 (1979).
Wiley, L. M. Curr. Topics dev. Biol. 13, 167–193 (1979).
Willison, K. R. & Stern, P. L. Cell. 14, 785–793 (1978).
Kapadia, A., Feizi, T. & Evans, M. J. Expl Cell Res. 131, 185–195 (1981).
Solter, D. & Knowles, B. B. Proc. natn. Acad. Sci. U.S.A. 75, 5565–5569 (1978).
Watanabe, K., Hakomori, S., Childs, R. A. & Feizi, T. J. boil. Chem. 254, 3221–3228 (1979).
Feizi, T., Childs, R. A., Watanabe, K. & Hakomori, S. J. exp. Med. 149, 975–980 (1979).
Niemann, H. et al. Biochem. biophys. Res. Commun. 81, 1286–1293 (1978).
Watkins, W. M. Adv. Hum. Genet. 10, 1–136, 379–385 (1980).
Fox, N. et al. Devl BioL (in the press).
Nudelman, E. et al. Biochim. biophys. Res. Commun. 97, 443–451 (1980).
Wood, E., Lecomte, J., Childs, R. A. & Feizi, T. Molec. Immun. 16, 813–819 (1979).
Lloyd, K. O., Kabat, E. A. & Licerio, E. Biochemistry 7, 2976–2990 (1968).
Watkins, W. M. & Morgan, W. T. J. Vox Sang. 4, 97–119 (1959).
Schiffman, G., Kabat, E. A. & Thompson, W. Biochemistry 3, 113–120 (1964).
Wood, E., Hounsell, E. F., Langhorne, J. & Feizi, T. Biochem. J. 187, 711–718 (1980).
Feizi, T. et al. J. exp. Med. 133, 39–52 (1971).
Koscielak, J. in Human Blood Groups (eds Mohn, J. F. et al. 143–149 (Karger, Basle, 1977).
Muramatsu, T. et al. Cell 18, 183–191 (1979).
Augé, C., David, S. & Veyrières, A. Nouv. J. Chim. 3, 491–497 (1979).
Feizi, T., Wood, E., Augé, S. & Veyrieres, A. Immunochemistry 15, 733–736 (1978).
Wood, E. & Feizi, T. FEBS Lett. 104, 135–140 (1979).
Kobata, A. Meth. Enzym. 28, 262–271 (1972).
Feizi, T. Revue fr. Transfusion Immuno-hemat. 23, 563–577 (1980).
Yang, H.-J. & Hakomari, S. J. biol. Chem. 246, 1192–1200 (1971).
Feizi, T., Kapadia, A., Gooi, H. C. & Evans, M. J. in Teratocarcinoma and Cell Surface (eds Muramatsu, T. & Ikawa, Y.) (Japan Scientific Societies Press, Tokyo, in the press).
Feizi, T. et al. J. Immun. 106, 1578–1592 (1971).
Szulman, A. E. in Human Blood Groups (eds Mohn, J. P. et al. 426–436 (Karger, Basle, (1977).
Prieels, J.-P. et al. Proc. natn. Acad. Sci. U.S.A. 75, 2215–2219 (1978).
Ziomek, C. A. & Johnston, M. H. Cell 21, 935–942, 1980.
Oppenheimer, S. B. Expl Cell Res. 92, 122–126 (1975).
Grabel, L. B., Rosen, S. D. & Martin, G. R. Cell 17, 477–484 (1979).
Neufeld, E. & Ashwell, G. in The Biochemistry of Glycoproteins and Proteoglycans (ed. Lennarz, W. J.) 241–266 (Plenum, New York, 1980).
Day, J. F., Thornburg, R. W., Thorpe, S. R. & Baynes, J. W. J. biol. Chem. 255, 2360–2365 (1980).
Stahl, P. et al. Cell 19, 207–215 (1980).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gooi, H., Feizi, T., Kapadia, A. et al. Stage-specific embryonic antigen involves αl→ 3 fucosylated type 2 blood group chains. Nature 292, 156–158 (1981). https://doi.org/10.1038/292156a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/292156a0
This article is cited by
-
Generation of fully functional hepatocyte-like organoids from human induced pluripotent stem cells mixed with Endothelial Cells
Scientific Reports (2019)
-
HLA and Histo-Blood Group Antigen Expression in Human Pluripotent Stem Cells and their Derivatives
Scientific Reports (2017)
-
Embryoglycan: a highly branched poly-N-acetyllactosamine in pluripotent stem cells and early embryonic cells
Glycoconjugate Journal (2017)
-
Changes of glycoconjugate expression profiles during early development
Glycoconjugate Journal (2017)
-
Glycosphingolipids of human embryonic stem cells
Glycoconjugate Journal (2017)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.